Search hospitals > North Carolina > Huntersville
Novant Health Presbyterian Medical Center Huntersville
Claim this profileHuntersville, North Carolina 28078
Conducts research for Parotid Gland Cancer
Conducts research for Breast Cancer
Conducts research for Cervical Adenocarcinoma
Conducts research for Relapse
Conducts research for Breast cancer
15 reported clinical trials
7 medical researchers
Summary
Novant Health Presbyterian Medical Center Huntersville is a medical facility located in Huntersville, North Carolina. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Cervical Adenocarcinoma, Relapse, Breast cancer and other specialties. Novant Health Presbyterian Medical Center Huntersville is involved with conducting 15 clinical trials across 72 conditions. There are 7 research doctors associated with this hospital, such as Alan Skarbnik, MD, Kimberly S. Strickland, Nasfat Shehadeh, M.D., and Obiageli U. Ogbata.Area of expertise
1Parotid Gland Cancer
Stage I
Stage II
Stage IV
2Breast Cancer
HER2 positive
ER negative
HER2 negative
Top PIs
Alan Skarbnik, MDNovant Health Presbyterian Medical Center5 years of reported clinical research
Studies Lymphoma
Studies Chronic Lymphocytic Leukemia
9 reported clinical trials
17 drugs studied
Kimberly S. StricklandNovant Health Presbyterian Medical Center1 year of reported clinical research
Studies Breast Cancer
Studies Breast cancer
5 reported clinical trials
17 drugs studied
Nasfat Shehadeh, M.D.Novant Health Presbyterian Medical Center10 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
5 reported clinical trials
11 drugs studied
Obiageli U. OgbataNovant Health Presbyterian Medical Center4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
8 drugs studied
Clinical Trials running at Novant Health Presbyterian Medical Center Huntersville
Lung Cancer
Breast Cancer
Small Cell Lung Cancer
Breast cancer
Prostate Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
ALK Gene Rearrangement
Relapse
Prostate Adenocarcinoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novant Health Presbyterian Medical Center Huntersville?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.